RS50780B - Farmaceutske kompozicije na bazi nk2 antagonista za pedijatrijsku primenu - Google Patents

Farmaceutske kompozicije na bazi nk2 antagonista za pedijatrijsku primenu

Info

Publication number
RS50780B
RS50780B RSP-2009/0169A RSP20090169A RS50780B RS 50780 B RS50780 B RS 50780B RS P20090169 A RSP20090169 A RS P20090169A RS 50780 B RS50780 B RS 50780B
Authority
RS
Serbia
Prior art keywords
cyclo
dap
trp
phe
leu
Prior art date
Application number
RSP-2009/0169A
Other languages
English (en)
Serbian (sr)
Inventor
Maria Altamura
Carlo Alberto Maggi
Alberto Aleotti
Original Assignee
Laboratori Guidotti S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Guidotti S.P.A. filed Critical Laboratori Guidotti S.P.A.
Publication of RS50780B publication Critical patent/RS50780B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
RSP-2009/0169A 2004-10-27 2005-10-26 Farmaceutske kompozicije na bazi nk2 antagonista za pedijatrijsku primenu RS50780B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000221A ITFI20040221A1 (it) 2004-10-27 2004-10-27 Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico
PCT/EP2005/055575 WO2006045820A1 (en) 2004-10-27 2005-10-26 Pharmaceutical compositions based on nk2 antagonists for pediatric use

Publications (1)

Publication Number Publication Date
RS50780B true RS50780B (sr) 2010-08-31

Family

ID=35613882

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2009/0169A RS50780B (sr) 2004-10-27 2005-10-26 Farmaceutske kompozicije na bazi nk2 antagonista za pedijatrijsku primenu

Country Status (25)

Country Link
US (2) US7727955B2 (enExample)
EP (1) EP1809267B1 (enExample)
JP (1) JP2008517977A (enExample)
CN (1) CN101052386A (enExample)
AR (1) AR051595A1 (enExample)
AT (1) ATE422881T1 (enExample)
AU (1) AU2005298629B2 (enExample)
CA (1) CA2584481C (enExample)
CY (1) CY1109803T1 (enExample)
DE (1) DE602005012857D1 (enExample)
DK (1) DK1809267T3 (enExample)
EA (1) EA012264B1 (enExample)
ES (1) ES2325413T3 (enExample)
HR (1) HRP20090225T1 (enExample)
IT (1) ITFI20040221A1 (enExample)
MX (1) MX2007004461A (enExample)
NO (1) NO338586B1 (enExample)
NZ (1) NZ555380A (enExample)
PL (1) PL1809267T3 (enExample)
PT (1) PT1809267E (enExample)
RS (1) RS50780B (enExample)
SI (1) SI1809267T1 (enExample)
UA (1) UA91988C2 (enExample)
WO (1) WO2006045820A1 (enExample)
ZA (1) ZA200703909B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614970D0 (en) * 2006-07-27 2006-09-06 R & D Sosei Ltd Compounds For Use In Therapy
IT1394304B1 (it) * 2009-05-21 2012-06-06 Malesci Sas Processo per la preparazione di ibodutant (men15596) e relativi intermedi
ITRM20120331A1 (it) * 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.
US20160051596A1 (en) * 2014-08-21 2016-02-25 Food Industry Research And Development Institute Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US9867857B2 (en) 2014-08-21 2018-01-16 Food Industry Research And Development Institute Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0219318A (ja) * 1988-06-30 1990-01-23 Carl R Thornfeldt 疝痛及び生歯に対する治療
IT1277835B1 (it) * 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
IT1307809B1 (it) * 1999-10-21 2001-11-19 Menarini Ricerche Spa Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
MY130373A (en) * 2001-10-29 2007-06-29 Malesci Sas Linear basic compounds having nk-2 antagonist activity and formulations thereof
GB0224788D0 (en) * 2002-10-24 2002-12-04 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
NO20072720L (no) 2007-07-09
US20080090795A1 (en) 2008-04-17
CN101052386A (zh) 2007-10-10
EA200700949A1 (ru) 2007-10-26
ITFI20040221A1 (it) 2005-01-27
ATE422881T1 (de) 2009-03-15
NO338586B1 (no) 2016-09-12
HRP20090225T1 (hr) 2009-05-31
EP1809267B1 (en) 2009-02-18
CY1109803T1 (el) 2014-09-10
EP1809267A1 (en) 2007-07-25
PT1809267E (pt) 2009-05-28
DE602005012857D1 (de) 2009-04-02
SI1809267T1 (sl) 2009-06-30
AU2005298629B2 (en) 2011-02-17
MX2007004461A (es) 2007-07-11
ZA200703909B (en) 2008-09-25
UA91988C2 (ru) 2010-09-27
DK1809267T3 (da) 2009-05-18
CA2584481C (en) 2014-07-15
AU2005298629A1 (en) 2006-05-04
PL1809267T3 (pl) 2009-07-31
US20100234284A1 (en) 2010-09-16
ES2325413T3 (es) 2009-09-03
HK1109335A1 (en) 2008-06-06
US7727955B2 (en) 2010-06-01
WO2006045820A1 (en) 2006-05-04
JP2008517977A (ja) 2008-05-29
EA012264B1 (ru) 2009-08-28
NZ555380A (en) 2008-12-24
CA2584481A1 (en) 2006-05-04
AR051595A1 (es) 2007-01-24

Similar Documents

Publication Publication Date Title
TWI361693B (en) Novel use of peptide compounds for treating essential tremor and other tremor syndromes
US20190209530A1 (en) Powder oral suspension formulations of antibacterial agents
US20200188358A1 (en) Methods for the treatment of depression
JP2021088575A (ja) Ｇｉ管障害を治療するための方法
AU2006305309A1 (en) Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
RS50780B (sr) Farmaceutske kompozicije na bazi nk2 antagonista za pedijatrijsku primenu
US8916524B2 (en) Composition for improving brain function and method for improving brain function
HK1109335B (en) Pharmaceutical compositions based on nk2 antagonists for pediatric use
El-Haddad et al. Neuropeptide Y administered into cerebral ventricles stimulates sucrose ingestion in the near-term ovine fetus
CN103108647B (zh) 脑功能改善用组合物及改善脑功能的方法
US8344101B2 (en) Composition for improving brain function and method for improving brain function
US20220362353A1 (en) Drug combination for preventing or treating irritable bowel syndrome
Laddie et al. symptoms in paediatric palliative care
JP2019189572A (ja) 運動バランス向上剤、及び敏捷性向上剤
KR20250021128A (ko) 세레브로리진을 유효성분으로 포함하는 근육질환의 예방 또는 치료용 조성물
US8343924B2 (en) Composition for improving brain function and method for improving brain function
AU2024202439A1 (en) Compositions and methods for treating epilepsy
UA122741C2 (uk) Пероральний лікарський препарат, що включає осмотичне проносне, поміщене в матрицю на основі рослинних жирів